These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1721204)

  • 1. Proarrhythmic response to antiarrhythmic drug as a risk factor for sudden cardiac death in patients with ischemic heart disease.
    Trusz-Gluza M; Giec L; Dabrowski A; Kuch J; Pasyk S; Piwowarska W; Pracka H; Sadowski Z; Wodniecki J
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1947-50. PubMed ID: 1721204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pro-arrhythmic effects of antiarrhythmic drugs in patients with ischemic heart disease].
    Trusz-Gluza M; Smieja-Jaroczyńska B; Szymkowiak-Rzechorzek E; Buszman P; Dabrowski A; Kuśnierz B; Lada W; Luczak D; Mroczek-Czernecka D; Piotrowicz R
    Kardiol Pol; 1990; 33(5):328-34. PubMed ID: 2074629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Does the appearance of pro-arrhythmic response to anti-arrhythmic drugs have prognostic significance?].
    Trusz-Gluza M; Giec L; Dabrowski A; Kuch J; Piwowarska W; Pracka H; Sadowski Z; Wodniecki J; Filipecki A; Szydło K
    Kardiol Pol; 1992 May; 36(5):280-3. PubMed ID: 1625409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can antiarrhythmic drugs survive survival trials?
    Pratt CM; Waldo AL; Camm AJ
    Am J Cardiol; 1998 Mar; 81(6A):24D-34D. PubMed ID: 9537220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological therapy in coronary heart disease: prevention of life-threatening ventricular tachyarrhythmias and sudden cardiac death.
    Kochs M; Eggeling T; Hombach V
    Eur Heart J; 1993 Sep; 14 Suppl E():107-19. PubMed ID: 8223747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arrhythmogenic effects of antiarrhythmic drugs in patients with an old myocardial infarction and asymptomatic ventricular ectopic activity as studied by programmed electrical stimulation.
    Farré J; Grande A; Albo PS; Martí F; Martínez-Romero P; Alfonso F; Rábago P
    Eur Heart J; 1987 Mar; 8 Suppl A():113-9. PubMed ID: 2438133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-arrhythmic drug prevention of sudden cardiac death--the status after the CAST study].
    Seipel L; Kühlkamp V
    Z Gesamte Inn Med; 1992 May; 47(5):189-94. PubMed ID: 1615728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inverse relationship between baseline left ventricular ejection fraction and outcome of antiarrhythmic therapy: a dangerous imbalance in the risk-benefit ratio.
    Pratt CM; Eaton T; Francis M; Woolbert S; Mahmarian J; Roberts R; Young JB
    Am Heart J; 1989 Sep; 118(3):433-40. PubMed ID: 2476016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prediction of long-term efficacy of amiodarone for refractory ventricular tachycardia: clinical significance of electrophysiologic study and Holter monitoring].
    Tsuchiya M; Kasanuki H; Ohnishi S; Hosoda S
    J Cardiol; 1996 Nov; 28(5):267-76. PubMed ID: 8953400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognosis of patients with sustained ventricular tachycardia and of survivors of cardiac arrest not inducible by programmed stimulation.
    Andresen D; Steinbeck G; Brüggemann T; Haberl R; Fink L; Schröder R
    Am J Cardiol; 1992 Nov; 70(15):1250-4. PubMed ID: 1442574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sudden cardiac death--possibilities and limits of drug therapy].
    Manz M; Lüderitz B
    Z Kardiol; 1992 May; 81(5):237-45. PubMed ID: 1621403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and timing of recurrences of sudden death and ventricular tachycardia during antiarrhythmic drug treatment after myocardial infarction.
    Rodriguez LM; Smeets J; O'Hara GE; Geelen P; Brugada P; Wellens HJ
    Am J Cardiol; 1992 Jun; 69(17):1403-6. PubMed ID: 1590227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Programmed electrical stimulation in patients with high-grade ventricular ectopy: electrophysiologic findings and prognosis for survival.
    Gomes JA; Hariman RI; Kang PS; El-Sherif N; Chowdhry I; Lyons J
    Circulation; 1984 Jul; 70(1):43-51. PubMed ID: 6202437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Holter monitoring in predicting efficacy of amiodarone therapy for sustained ventricular tachycardia associated with coronary artery disease.
    Nasir N; Doyle TK; Wheeler SH; Pacifico A
    Am J Cardiol; 1994 Mar; 73(8):554-8. PubMed ID: 7511872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.